Norditropin NordiFlex®
A smooth treatment experience means continually developing devices that are convenient and easy to use
Norditropin NordiFlex® — simplicity by design
Easy to use
Norditropin NordiFlex® pens are prefilled and preloaded with the medication and have an easy to use dosing dial. Current Norditropin NordiFlex® pens require up to 42% less injection force than the previous NordiFlex™ 5 mg/1.5 mL, 10 mg/1.5 mL, and 15 mg/1.5 mL pens.1, 2 Quick setup and administration make the use of current NordiFlex™ pens easy to teach, and their convenient size makes them easy to take anywhere.3,*
Easy to store*
NordiFlex™ 5 mg/1.5 mL and 10 mg/1.5 mL pens can be left at room temperature after initial use.4
* All Norditropin® products must be refrigerated prior to first use. Do not freeze. After initial use, Norditropin NordiFlex® 5 mg/1.5 mL and 10 mg/1.5 mL delivery pens can either be stored outside of the refrigerator (at up to 77ºF) for use within three weeks, or in the refrigerator (between 36°F and 46°F) for use within four weeks. These storage flexibility guidelines also apply to Norditropin® cartridge 5 mg/1.5 mL. Norditropin NordiFlex® 15 mg/1.5 mL and Norditropin NordiFlex® 30 mg/3 mL delivery pens must always be refrigerated (between 36ºand 46ºF) - both prior to and after the initial injection – for use within four weeks. These guidelines for continuous refrigerated storage also apply to Norditropin® cartridge 15 mg/1.5 mL.
The Norditropin® Device Pledge
If, after filling three paid prescriptions for Norditropin®, your patient is not satisfied with his or her pen, Novo Nordisk will pay up to $125 of the patient’s first copay for a competing medication.†
† Norditropin® Device Pledge Terms and Conditions
Patients must be new to therapy with Norditropin®, but could have previously taken a competing product. Patients receiving copay assistance with NordiSure™ are eligible. Patients must provide proof of three paid months of therapy with Norditropin® in compliance with their treatment plan, proof of purchase of a competing product, and a letter stating the reason why they are dissatisfied. Offer expires 60 days after the date of the last script filled by a pharmacy. Patients cannot be receiving copay assistance or a free product from the manufacturer of a competing product. Novo Nordisk reserves the right to rescind, revoke, or amend this offer without notice at any time. This offer is not valid for individuals who are covered by Medicaid or Medicare and in certain states. Not valid for residents of Massachusetts. Offer good only in the United States.
With NordiFlex PenMate™, patients perceived significantly less pain10
Designed and intended for use with NordiFlex™ 5 mg/1.5 mL, 10 mg/1.5 mL, and 15 mg/1.5 mL prefilled pens and NovoFine® disposable needles. Not to be used with the 30 mg/3 mL pen.
The NordiFlex PenMate™ has been shown to reduce perception of pain.4 The needle is hidden from sight during the injection process, and the insertion button allows the needle to be automatically inserted quickly, with a single touch.
References
- Data on file. Injection force dynamics at constant injection button speed conditions for present and improved version of Norditropin NordiFlex®, 10 mg. Princeton, NJ: Novo Nordisk Inc; 2008.
- Data on file. Injection force dynamics at three injection button speed conditions for present and improved version of Norditropin NordiFlex®, 10 mg: tests with a G32 needle. Princeton, NJ: Novo Nordisk Inc; 2008.
- Data on file. Norditropin NordiFlex® 30 mg/3 mL: Development and comparison to Norditropin NordiFlex® 15 mg/1.5 mL. Princeton, NJ: Novo Nordisk Inc; 2008.
- Diglas J, Feinböck C, Winkler F, et al. Reduced pain perception with PenMate™, an automatic needle insertion device for use with an insulin pen. Practical Diabetes Int. 1999;16(2):39-41.
